Proteome Sciences plc (LON:PRM – Get Free Report)’s stock price was up 9% on Monday . The company traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.35 ($0.04). Approximately 967,070 shares were traded during trading, an increase of 496% from the average daily volume of 162,146 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Stock Performance
The company has a market capitalization of £9.89 million, a P/E ratio of -335.00 and a beta of 0.07. The business has a fifty day moving average of GBX 2.71 and a 200-day moving average of GBX 3.16.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- What is a support level?
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- Canadian Penny Stocks: Can They Make You Rich?
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- What is the NASDAQ Stock Exchange?
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
